|
|
| n (%) |
| sex | male | 47 (81) |
|
| female | 11 (19) |
| chemotherapy | no | 18 (31) |
|
| yes | 40 (69) |
| entity (total radiation dose) | SCLC (60 Gy) | 10 (17) |
|
| Esophageal CA (66 Gy) | 25 (43) |
|
| NSCLC (74 Gy) | 23 (40) |
| smoking history | never | 5 (9) |
|
| present | 30 (52) |
|
| former | 23 (40) |
| UICC stage * NSCLC/SCLC | IIIa | 2 (3) |
| IIIb | 11 (19) | |
|
| IIIc | 17 (29) |
|
| IV | 3 (5) |
| UICC stage * Esophageal carcinoma | Ib | 2 (3) |
| IIIa | 4 (7) | |
|
| IIIb | 12 (21) |
|
| IV | 7 (12) |
| total |
| 58 (100) |